Source: Pharmabiz

UNIMIB: Windtree extends collaboration with University of MilanBicocca to discover & develop new SERCA2a compounds to treat chronic and acute human heart failure

Windtree Therapeutics, Inc., a biotechnology and medical device company, announced the company is extending its collaboration with the University of Milan─Bicocca

Read full article »

UNIMIB's Competitors | UNIMIB's News | UNIMIB's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Update CEO

CEO Approval Rating

- -/100

UNIMIB is an Italy-based educational institution that offers courses in disciplines such as master of science degree, mathematics, and biology for individuals.